Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:45:57.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the study information, blocking access to the NCT03832569 details and related content while the site chrome remains visible.
    Difference
    17%
    Check dated 2026-09-21T20:24:24.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study record shows a revision update to v3.6.6. This indicates a minor maintenance/formatting update to the page rather than a change to study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-08-31T18:14:36.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.6.5 appears on the page, replacing v3.6.4. This reflects a minor internal template update with no change to study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T12:54:05.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page now shows a new revision tag (v3.6.4) replacing the previous v3.6.3. This indicates a minor maintenance update to the page rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-27T06:29:16.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a version update to the page template. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-07-05T11:16:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.